All News

PHILADELPHIA -- Performance measures for hospitals adopted by Medicare and the Joint Commission on Accreditation of Healthcare Organizations may only be loosely related to patient outcomes.

PHILADELPHIA -- Performance measures for hospitals adopted by Medicare and the Joint Commission on Accreditation of Healthcare Organizations may only be loosely related to patient outcomes.

ORLANDO -- For preventing recurrent DVT, once-weekly idraparinux, an investigational synthetic oligosaccharide, was comparable to the combination of low-molecular-weight heparin and a daily vitamin K antagonist, Dutch researchers reported here.

ORLANDO -- For some patients with acute myeloid leukemia, an unfavorable prognostic marker could mean a better response to allogeneic stem cell transplantation, a German-Austrian research team reported here.

PHILADELPHIA -- For Medicare-age prostate cancer patients, action extends survival better than observation, according to investigators here.

PHILADELPHIA -- For Medicare-age prostate cancer patients, action extends survival better than observation, according to investigators here.

ORLANDO -- For older patients with follicular lymphoma, the addition of Rituxan (rituximab) to standard CHOP chemotherapy boosted overall response rates, prolonged time to treatment failure, and improved overall survival.

ORLANDO -- An investigational oral platelet growth factor increased platelet levels in patients with chronic idiopathic thrombocytopenic purpura (ITP) reported investigators here.

HEIDELBERG, Germany -- Older children in big families may be at elevated risk of brain and other nervous system tumors, according to a large epidemiologic study.

NEWARK, N.J. -- Whole-body Swedish massage proved safe and effective in reducing pain and improving function in osteoarthritis of the knee, according to a pilot study.

ORLANDO -- Antibody-directed therapy added to induction chemotherapy for acute myeloid leukemia (AML) improved disease-free survival without major added toxicity, international researchers reported here.

CAMPOBASSO, Italy -- Moderate drinking has a protective effect on all-cause mortality, not only coronary heart disease, according to a meta-analysis of 34 prospective studies.

ORLANDO -- For chromic myeloid leukemia patients who develop resistance or are refractory to Gleevec (imatinib), nilotinib is waiting in the wings, according to an international evaluation.

RESEARCH TRIANGLE PARK, N.C. -- Major hormonal contraception methods appear to have little or no effect on HIV susceptibility for women at moderate risk, according to a study of more than 4,000 African women.

ORLANDO -- Mesenchymal stem cells derived from bone marrow show promise for severe steroid-resistant graft-versus-host disease, reported European investigators here.

GAITHERSBURG, Md. -- Midway through a two-day FDA hearing on the safety of drug-eluting coronary stents the hard questions were still open.

GAITHERSBURG, Md. -- The FDA's drug-eluting stent advisory panel recommended today that the agency change the labels of the two approved coronary devices to warn that off-label use may increase the risk of thrombosis, myocardial infarction, and death.

LEEDS, England -- Once again the question of whether women ages 40 to 49 should have routine screening mammograms has arisen.